𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Prognostic value of p53 protein and MK-1 (a tumor-associated antigen) expression in gastric carcinoma

✍ Scribed by M. Salih Deveci; Güzin Deveci


Publisher
Springer
Year
2007
Tongue
English
Weight
324 KB
Volume
10
Category
Article
ISSN
1436-3291

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Prognostic value of cyclin E and p53 exp
✍ Teruyuki Sakaguchi; Akihiko Watanabe; Hidetomo Sawada; Yukishige Yamada; Jun Yam 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 236 KB 👁 2 views

With regard to prognosis, patients whose tumors had both First Department of Surgery, Nara Medical Unistrong positivity for cyclin E and positivity for p53 had significantly poorer prognosis. versity, Nara, Japan. In multivariate analysis, the combined variable of cyclin E and p53 was an independen

The prognostic value of cyclin D1, p53,
✍ Coupland, Sarah E.; Anastassiou, Gerasimos; Stang, Andreas; Schilling, Harald; A 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 215 KB 👁 2 views

Malignant uveal melanoma is the commonest primary intraocular tumour in adults. It metastasizes frequently and 50% of patients die within 10 years of diagnosis. The expression of cyclin D1, p53, and MDM2 in uveal melanoma and their relationship to metastasis-free 5-year survival was determined, in o

Immunohistochemical detection of p53 pro
✍ Sredni, Simone Treiger ;de Camargo, Beatriz ;Lopes, Luiz Fernando ;Teixeira, Rob 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB

## Abstract ## Background Mutations of the tumor suppressor gene p53 are commonly found in several kinds of human cancer. In some types of neoplasms, accumulation of p53 protein has been reported to correlate with more aggressive clinical behavior. The role of p53 expression in Wilms tumors (WT) i

Prognostic value of p53, bcl-2, and c-er
✍ de Krijger, Ronald R.; van der Harst, Erwin; van der Ham, Frieda; Stijnen, Theo; 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 260 KB 👁 2 views

Many studies have tried to discriminate malignant from benign phaeochromocytomas, but until now no widely accepted histological, immunohistochemical, or molecular methods have been available. In this study of 29 malignant and 85 benign phaeochromocytomas from 102 patients, immunohistochemistry was p